I was in then as well. Figured that it had a lot of potential outside bio. Still do, even though they really only had an idea in the begining. After the new board came in with the bigger vision it started to look good. Spent a lot averaging down, but it has paid off in spades and IMO this is just the start. The applications in the future haven't even been thought of yet. It will be driven by accountability. Even in the bio space productivity gains are mammoth let alone the risk accociated with sample mixups.
My old man nearly died because of a blood bag mix up. That was before the age of litigation.
- Forums
- ASX - By Stock
- BCT
- Chartwatch
Chartwatch, page-16
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BCT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.737M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
BCT (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online